Home Blog Page 1466

SANY Commences Operations at its First Engineering Machinery Remanufacturing Base in Hainan

By
Advertorial Desk
-

DONGFANG, China, Dec. 30, 2025 /PRNewswire/ — SANY Group officially commenced operations of its first global engineering machinery remanufacturing base, the SANY Hunan-Hainan Intelligent Manufacturing Industrial Park (the “Park”), on December 23 in Dongfang City of Hainan Province. The event marks a key milestone in SANY’s globalization and sustainability strategy, and on the opening day, the group secured orders worth CNY100 million (USD14.27 million) from Southeast Asia and Africa.

SANY Launches First Global Engineering Machinery Remanufacturing Base in Hainan
SANY Launches First Global Engineering Machinery Remanufacturing Base in Hainan

The Park is China’s first industrial park co-constructed by a pilot free trade zone (FTZ) and a pilot free trade port, and it is taking the cross-regional linkage development of Hunan and Hainan a step further, leveraging both provinces’ respective industrial and policy advantages to support Chinese companies in expanding their global footprint.

The Park, which commenced construction in August 2023, covers an area of 150 mu (approximately 10 hectares). And with a total investment of CNY600 million (USD85.62 million), it’s expected to achieve an annual output value of about CNY750 million (USD107.02 million) once operating at full capacity.

Strategically positioned as a regional remanufacturing center and resource distribution platform serving both domestic and international markets, the Park focuses on the maintenance and remanufacturing of core engineering machinery components and second-hand equipment from domestic and international markets, promoting the circular reuse of industrial resources.

In addition, under the framework of the Hainan FTZ, eligible value-added processing activities are entitled to tariff preferences, while remanufacturing operations can be conducted under bonded supervision and may qualify for corporate and personal income‑tax incentives. ThePark benefits from the “Dual 15%” tax‑incentive policy and has received approval for its outsourced processes to enjoy a 15% corporate income‑tax reduction.

“The project represents a key strategic initiative for SANY to deepen its globalization, digitalization, and low-carbon transformation. Moving forward, SANY will continue to actively explore new models for remanufacturing, promote the circular reuse of industrial resources, and jointly advance the global engineering machinery industry’s transition toward a greener, low-carbon future,” said Tang Xiuguo, Chairman of SANY.

 

Empowering an Affordable Energy Future with Solar Energy Solutions by Felicitysolar

By
Advertorial Desk
-

The Rise of Solar Energy Battery Storage Systems in the U.S. Market

GUANGZHOU, China, Dec. 30, 2025 /PRNewswire/ — As energy costs continue to rise, more and more households and businesses in the U.S. are turning to solar energy solutions to reduce their electricity bills. According to the latest data from the U.S. Energy Information Administration (EIA), the average residential electricity price for 2025, as of October, has reached $17.27 per month, surpassing the average of $16.48 for the entirety of 2024. Similarly, the average commercial electricity price for 2025, as of October, has risen to $13.48, compared to the average of $12.75 in 2024.

This increasing energy cost is driving demand for solar energy storage systems, which allow users to maximize the benefits of their solar energy production while saving on electricity costs. As a leading solar energy company, Felicitysolar continues to innovate in providing off-grid and hybrid solar energy storage solutions.

Key Considerations When Choosing Solar Energy Storage Systems in the U.S.
When selecting a solar energy battery storage system in the U.S., users typically focus on several key factors to ensure reliability, safety, and efficiency:

1. Safety and Compliance
Safety is a top concern for users. Felicitysolar addresses this by integrating fire protection modules into its critical models. Additionally, key products such as the LUX-X-48100LG01-US and LUX-Y-48280LG01 have earned UL9540A, UL1973, FCC, and UL60730 certifications, meeting the rigorous safety standards required in the U.S. market.

2. Data Visualization and Smart Monitoring
As solar energy solutions become more sophisticated, users increasingly seek systems that offer smart monitoring capabilities. Platforms like the one offered by Felicitysolar allow users to monitor their system’s performance in real time, providing intuitive insights to help manage energy consumption and optimize energy use.

3. Reliability
Ensuring that systems remain operational without interruptions is essential for many consumers. Features like real-time fault detection and alerts are commonly integrated into advanced systems, helping users quickly address any issues that may arise. This focus on reliability is key to maintaining a consistent energy supply.

4. Ease of Installation
Simplifying installation is crucial for both installers and users. Felicitysolar products are designed with features like external fuse designs (FLB series 24V and 48V LiFePO4 batteries), integrated grounding bracketsand battery modules automatic addressing (FLH series 48V100Ah, FLH48100UG2). These thoughtful features reduce installation time and complexity, ensuring a more cost-effective and efficient setup process.

Felicitysolar: Expertise and R&D Strength
Founded in 2007, Felicitysolar has accumulated nearly 20 years of experience in the solar energy industry, providing cutting-edge solar energy solutions globally. With more than 170 patented technologies, the company remains committed to continuous innovation. Every year, they invest 10% of their revenue into R&D, and by 2026, they aim to expand their R&D team to over 400 experts. Meanwhile, a new photovoltaic and energy storage R&D and manufacturing base project was officially launched on December 25, with a total construction area of nearly 190,000 square meters and a site area of 50,539 square meters, further strengthening the company’s long-term research and innovation capabilities.

Their advanced technology portfolio includes a wide range of products such as solar energy battery storage, off grid inverters, hybrid inverters, and lithium batteries in various configurations, including 12V, 24V, and 48V LiFePO4 batteries, to meet the diverse needs of their customers.

Looking Ahead: The New Year of Service
As Felicitysolar steps into 2026, they are placing an even greater emphasis on customer service, alongside their ongoing commitment to product quality. The company is proud to announce that 2026 will be their “Year of Service,” focusing on providing fast and efficient delivery services, pre- and post-sales support, technical assistance, and marketing guidance to help build long-term trust with their partners.

Felicitysolar is dedicated to making solar energy solutions more accessible and reliable for everyone, aiming to provide a more sustainable and greener energy future for all.

Empowering an Affordable Energy Future with Solar Energy Solutions by Felicitysolar
Empowering an Affordable Energy Future with Solar Energy Solutions by Felicitysolar

CONTACT:
Felicitysolar
https://felicitysolar.com
sales@felicitysolar.com 

Delixy Holdings Limited Reports Unaudited Financial Results for the First Six Months of Fiscal Year 2025

By
Advertorial Desk
-

SINGAPORE, Dec. 30, 2025 /PRNewswire/ — Delixy Holdings Limited (Nasdaq: DLXY) (the “Company” or “Delixy”), a Singapore-based company engaged in the trading of oil related products, today announced its unaudited financial results for the six months ended June 30, 2025.

First Six Months of Fiscal Year 2025 Financial Summary

  • Revenue was $102.0 million for the six months ended June 30, 2025, compared to $143.8 million for the same period last year.
  • Gross profit was $1.1 million for the six months ended June 30, 2025, compared to $1.8 million for the same period last year.
  • Net income was $0.6 million for the six months ended June 30, 2025, an increase from $0.5 million for the same period last year.
  • Basic and diluted income per share was $0.04 for the six months ended June 30, 2025, an increase from $0.03 for the same period last year.

Mr. Dongjian Xie, Executive Chairman and Chief Executive Officer of Delixy, commented, “During the first half of fiscal year 2025, we remained focused on efficiency while navigating a dynamic market environment. This approach allowed us to strengthen profitability and deliver improved operating results. While revenues during the period reflected softer market activity, our general and administrative expenses declined significantly year-over-year, reflecting streamlined corporate operations and strong expense controls. As a result, our profits from operations increased to $0.4 million from $0.2 million for the same period last year, and net income rose to $0.6 million from $0.5 million.

“On July 9, 2025, our ordinary shares commenced trading on Nasdaq following our initial public offering (the “IPO”), marking a major milestone for Delixy. The IPO strengthened our balance sheet, enhanced our visibility in the capital markets, and further improved our corporate governance framework. Looking ahead, we plan to continue to emphasize disciplined execution and prudent growth initiatives. With the foundation established as a public company, we believe Delixy is well positioned to pursue sustainable growth and create long-term value for our shareholders.”

First Six Months of Fiscal Year 2025 Unaudited Financial Results

Revenues

Revenues were $102.0 million for the six months ended June 30, 2025, a decrease from $143.8 million for the same period last year. The decrease was primarily attributable to the lower selling price, following weak oil demand and lower international oil price in first half of 2025.

Cost of Revenue

Cost of revenue was $100.9 million for the six months ended June 30, 2025, a decrease from $142.0 million for the same period last year. The decrease was primarily due to a weaker world oil market, with lower oil price we traded in. 

Gross Profit

Gross profit was $1.1 million for the six months ended June 30, 2025, a decrease from $1.8 million for the same period last year.

General and Administrative Expenses

General and administrative expenses were $0.7 million for the six months ended June 30, 2025, a decrease from $1.6 million for the same period last year. The decrease was primarily driven by less vessel chartering and less logistics expense due to a high stocks of crude oil and oil products in far east.

Net Income

Net income was $0.6 million for the six months ended June 30, 2025, an increase from $0.5 million for the same period last year.

Basic and Diluted Income per Share

Basic and diluted income per share was $0.04 for the six months ended June 30, 2025, an increase from $0.03 for the same period last year.   

Financial Condition

As of June 30, 2025, the Company had cash and cash equivalents of $1.8 million, compared to $5.6 million as of June 30, 2024.

Net cash used in operating activities was $0.6 million for the six months ended June 30, 2025, compared to $1.4 million for the same period last year.

Net cash used in investing activities was $0.5 million for the six months ended June 30, 2025, compared to net cash provided of $1.3 million for the same period last year.

Net cash used in financing activities was $2.7 million for the six months ended June 30, 2025, compared to $2.5 million for the same period last year.

About Delixy Holdings Limited

Delixy Holdings Limited is a Singapore-based company principally engaged in the trading of oil-related products, including (i) crude oil and (ii) oil-based products such as fuel oils, motor gasoline, additives, gas oil, base oils, asphalt, naphtha (heavy gasoline) and petrochemicals. Operating across multiple countries in Southeast Asia, East Asia, and Middle East, Delixy has established a strong presence in the region’s oil trading markets. While Delixy maintains a diversified portfolio of oil products, crude oil trading represents a core aspect of its business. The Company leverages its strong existing relationships with customers and suppliers as well as deep industry expertise to provide value-added services, including tailored recommendations on optimal trading strategies and shipping and logistical support where required. In addition, the Company’s financing capabilities allow it to extend credit terms to customers while satisfying suppliers’ immediate payment terms. For more information, please visit the Company’s website: https://ir.delixy.com.

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs. Investors can find many (but not all) of these statements by the use of words such as “believe”, “plan”, “expect”, “intend”, “should”, “seek”, “estimate”, “will”, “aim” and “anticipate” or other similar expressions in this prospectus. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Registration Statement and other filings with the U.S. Securities and Exchange Commission (the “SEC”).

For media inquiries, please contact:

Delixy Holdings Limited
Investor Relations Department
Email: ir@delixy.com

Ascent Investor Relations LLC
Tina Xiao
Phone: +1-646-932-7242
Email: investors@ascent-ir.com

 

DELIXY HOLDINGS LIMITED AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

(Amount in USD thousands, except for share and per share data, or otherwise noted)

As of Jun 30, 
2024

As of Jun 30,
2025

US$’000

US$’000

ASSETS

Current assets:

Cash and cash equivalents

5,609

1,824

Accounts receivable, net

3,772

18,648

Deposits, prepayments and other receivables

34

502

Derivative financial instruments

312

831

Total current assets

9,727

21,805

Non-current assets:

Property and equipment, net

4

1

Right-of-use assets, net

99

37

Deferred offering costs

1,152

2,492

Total non-current assets

1,255

2,530

TOTAL ASSETS

10,982

24,335

LIABILITIES AND SHAREHOLDERS’ EQUITY

Current liabilities:

Accounts payable

2,521

18,227

Accrued liabilities

87

51

Dividend payables

2,245

Amount due to shareholder

99

1

Lease liabilities

62

38

Income tax payable

157

105

Total current liabilities

5,171

18,422

Non-current liabilities:

Lease liabilities

36

Loan from shareholder

5,000

4,000

Non-current liability

5,036

4,000

TOTAL LIABILITIES

10,207

22,422

Commitments and contingencies

—

—

Shareholders’ equity:

Ordinary share, par value US$0.000005, 100,000,000,000 shares authorized,

15,000,000 shares issued*

**

**

Additional paid-up capital

695

695

Retained earnings

34

1172

Other reserve

46

46

Total shareholders’ equity

775

1,913

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

10,982

24,335

____________

*        Retrospectively restated for the effect of 1:200 forward stock split of our Ordinary Shares and the shares surrendered by our existing shareholders.
**      — Denotes amount less than US$1,000.

 

 

DELIXY HOLDINGS LIMITED AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME

(UNAUDITED)

(Amount in USD thousands, except for share and per share data, or otherwise noted)

For the six months period ended
June 30,

2024

2025

US$’000

US$’000

Revenues

143,761

102,000

Cost of revenue

(141,959)

(100,925)

Gross profit

1,802

1,075

General and administrative expenses

(1,635)

(692)

Profits from operations

167

383

Other income:

Gain on disposal of property

177

Foreign exchange gain

1

8

Interest income

135

35

Shipping charges reimbursed

10

201

Other income

5

1

Total other income

328

245

Income before income tax

495

628

Income tax expense

(45)

(68)

NET INCOME

450

560

TOTAL COMPREHENSIVE INCOME

450

560

Net income per share

Basic and diluted**

0.030

0.037

Weighted average number of ordinary shares outstanding Basic and diluted**

15,000,000

15,000,000

____________

*        — Denotes amount less than US$1,000.
**      Retrospectively restated for the effect of 1:200 forward stock split of our Ordinary Shares and the shares surrendered by our existing shareholders.

 

 

DELIXY HOLDINGS LIMITED AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOW

(UNAUDITED)

(Amount in USD thousands, except for share and per share data, or otherwise noted)

For the six months period ended
June 30,

2024

2025

US$’000

US$’000

Cash flows from operating activities:

Net income after tax

450

560

Depreciation of property and equipment

7

3

Amortization of right-of-use assets

20

25

Gain on disposal of property

(177)

Interest expense

89

(88)

Change in working capital:

Accounts receivable, net

(3,059)

(14,876)

Deposits, prepayments and other receivables

1

(468)

Other non-current assets

(1,152)

(1,340)

Accounts payable

2,521

15,706

Accrued liabilities

12

(36)

Lease liabilities

(22)

(23)

Income tax payable

(89)

(52)

Net cash provided by/(used in) operating activities

(1,399)

(589)

Cash flows from investing activities:

Derivative financial instruments

295

(519)

Proceeds from disposal of property

957

Amount due from shareholder

—

Net cash (used in)/provided by investing activities

1,252

(519)

Cash flows from financing activities:

Amount due to related party

—

Amount due to shareholder

11

(10)

Dividend paid

(2,500)

(2,667)

Net cash used in financing activities

(2,489)

(2,677)

Net change in cash and cash equivalents

(2,636)

(3,785)

BEGINNING OF FINANCIAL PERIOD

8,245

5,609

END OF FINANCIAL PERIOD

5,609

1,824

Supplemental Cash Flow Information:

Cash paid for income taxes

(134)

(90)

Cash paid for interest

(1)

(5)

Supplemental schedule of noncash financing activities

Loan from shareholder

5,000

4,000

 

The centenarian Palace Museum: How a ‘zero-waste’ initiative breathes green vitality into China’s landmark heritage?

By
Advertorial Desk
-

BEIJING, Dec. 30, 2025 /PRNewswire/ — A news report from China.org.cn on the Palace Museum:

The centenarian Palace Museum: How a ‘zero-waste’ initiative breathes green vitality into China’s landmark heritage?

https://youtu.be/fZg27rA1E5E

On October 11, 2025, the 7th Taihe Forum, hosted by the Palace Museum and the Forbidden City Cultural Heritage Conservation Foundation, kicked off. Throughout the forum, the concept of green development took center stage. What tangible efforts have been made to bring a “green Palace Museum” to life? Let’s step into the Palace Museum and uncover the answers!

As a world-renowned cultural landmark, the Palace Museum welcomes an average of over 10 million visitors each year. This massive foot traffic, however, brings immense pressure from waste generation. In January 2020, the “Zero Waste at the Palace Museum” project was launched. Astute visitors will notice that the Palace Museum has refined its waste sorting system, expanding from the standard four major categories to seven detailed subcategories. Even a single plastic bottle or scrap of paper now has its own designated bin, significantly boosting sorting efficiency. But where do these recycled plastic bottles end up? They are given a new lease on life as the Palace Museum cultural and creative products.

Wu Di（Director, Department of Cultural Products/The Palace Museum）: Inside, there are also some common daily necessities of ours. Such as this tote bag. There is a clear label on it. It means that this tote bag is made from 9 recycled mineral water bottles as raw materials. In addition, this tote bag extracts elements from cultural relics and includes relevant introductions. Of course, it has some carbon reduction labels. For example, this tote bag has reduced carbon emissions by 630 grams. The message conveyed by such a cultural and creative product is not only the information about cultural relics and culture it carries. It also conveys a new trend of fashion.

These eco-friendly products are available in the Palace Museum’s souvenir stores, letting visitors take home a “green memory of the Palace Museum.”

The area around the Gate of Good Fortune is a hub for dining at the Palace Museum. Over the nearly six years since the zero-waste project launched, the zero-waste catering culture week has become a regular event, promoting initiatives like the “Clean Plate Campaign,” proper waste sorting, and bringing reusable water bottles. Through these efforts, visitors have shifted from mere onlookers of zero-waste practices to active participants, gaining first-hand experience of the value of a green lifestyle.

Another highlight drawing visitors to snap photos is the new ecological composting flower bed on the east side of the Archery Pavilion Plaza. This space houses over 50 species of native plants, along with landscape rocks, lotus tanks, and eco-friendly facilities like compost bins, earthworm towers, and insect hotels. Within this micro-ecosystem, waste is converted into organic fertilizer that nourishes the garden’s greenery, enabling this ancient cultural heritage site to achieve a self-sustaining green cycle.

After following this “zero-waste route” through the Palace Museum, standing back at the starting point and gazing at the complex, one can’t help but recall the Hall of Supreme Harmony, the Hall of Central Harmonyand the Hall of Preserving Harmony. The character meaning “harmony,” which appears repeatedly on the plaques of these halls, seems to echo the Palace Museum’s age-old wisdom of harmonious coexistence between humans and nature– a principle that remains the spiritual cornerstone of today’s “Green Palace Museum” initiative.

The centenarian Palace Museum: How a ‘zero-waste’ initiative breathes green vitality into China’s landmark heritage?

http://www.china.org.cn/2025-11/24/content_118192539.shtml

 

Euro Tech Holdings Company Limited Reports Interim Results For The Six Months Ended June 30, 2025

By
Advertorial Desk
-

HONG KONG, Dec. 30, 2025 /PRNewswire/ — Euro Tech Holdings Company Limited (Nasdaq: CLWT) today reported its unaudited financial results for the six months ended June 30, 2025.

The Company’s revenue for the six months ended June 30, 2025 (“1H 2025”) were US$5,888,000, a 18.9% decrease as compared to  US$7,259,000 for the six months ended June 30, 2024 (“1H 2024”). Revenue from trading activities decreased significantly, primarily due to lowered sales of U.S. products to China following U.S. tariffs and Chinese retaliatory measures.

Gross profit decreased by 5.2% to US$1,697,000 for 1H 2025 as compared to US$1,790,000 for 1H 2024. The decrease was due to the decrease in revenue. However the gross profit margin % for 1H 2025 increased by 4.2% to 28.8% as compared to 24.6% for 1H 2024.

General and administrative expenses decreased by US$102,000 to US$2,065,000 for 1H 2025 as compared to US$2,167,000 for 1H 2024.

The Company’s net loss for 1H 2025 was US$127,000 as compared to net income of US$44,000 for 1H 2024 resulting from decrease in revenue and equity in income of affiliate.

Mr. David Leung, CEO of the company commented,

 “Despite the challenging business environment, we have seen a remarkable increase in sales orders, achieving double-digit growth in the first half of the year. This growth is primarily driven by heightened engineering activities in water and wastewater treatment (“WWT”), although the delivery timelines will be extended until the end of this year or early next year.

Recently, we have also secured additional purchase orders from international markets, including Mongolia, Norway, and Dubai, for both WWT and ballast water treatment systems (“BWTS”). 

In the coming days, we intend to diversify our sales channels and explore new product applications in high-growth regions and industries to further leverage this momentum.”

About BWTS

BWTS are an imminent requirement by The International Maritime Organization (“IMO”) to prevent the biological unbalance caused by the estimated 12 billion tons of ballast water transported across the seas by ocean-going vessels when their ballast water tanks are emptied or refilled. In 2012, ballast water discharge standard became a law in the US. Any vessel constructed in December 2013 or later will need to comply when entering US waters, and existing vessels will follow shortly after. IMO’s Ballast Water Management Convention entered into force for new-built vessels on September 8, 2017 after ratification by 52 States, representing 35.1441% of world merchant shipping tonnage. In July 2017, IMO decided that the phase-in period for ballast water system retrofits started on 8 September 2019. 

The company obtained type approval certificate from China’s Classification Society for its 200, 300, 500, 750, 1200 and 1250 Cubic Meters per hour BWTS in 2016.

The IMO convention stipulates that type approval for revised G8 requirements must be obtained for all BWTS installed on or after October 28, 2020, and the company have been in compliance with such requirements.

The ballast water port solution system is a system installed in port to offer ballast water treatment services for ocean going ships without their own BWTS and for those with damaged BWTS.

Certain statements in this news release regarding the Company’s expectations, estimates, present view of circumstances or events, and statements containing words such as estimates, anticipates, intends, or expects, or words of similar import, constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements indicate uncertainty and the Company can give no assurance with regard to actual outcomes. Specific risk factors may include, without limitation, having the Company’s offices and operations situated in Hong Kong and China, doing business in China, competing with Chinese manufactured products, competing with the Company’s own suppliers, dependence on vendors, and lack of long term written agreements with suppliers and customers, development of new products, entering new markets, possible downturns in business conditions, increased competition, loss of significant customers, availability of qualified personnel, negotiating definitive agreements, new marketing efforts and the timely development of resources. See the “Risk Factor” discussions in the Company’s filings with the Securities and Exchange Commission, including its Annual Report on Form 20-F for its fiscal year ended December 31, 2024.

EURO TECH HOLDINGS COMPANY LIMITED

CONSOLIDATED BALANCE SHEETS

As of

June 30,

2025

(Unaudited)

As of

December 31,

2024

(Audited)

US$’000

US$’000

ASSETS

Current assets:

Cash and cash equivalents

4,493

5,805

Restricted cash

1,517

1,132

Accounts receivable, net

1,342

1,386

Prepayments and other current assets

437

271

Contract assets

80

135

Inventories

302

500

──────

──────

Total current assets

8,171

9,229

──────

──────

Property, plant and equipment, net

157

159

Investments in affiliates

9,774

9,947

Goodwill

1,071

1,071

Operating lease right-of-use assets, net

231

101

Deferred tax assets

80

62

Restricted cash

315

139

──────

──────

Total non-current assets

11,628

11,479

──────

──────

TOTAL ASSETS

19,799

20,708

══════

══════

LIABILITIES AND SHAREHOLDERS’ EQUITY

Current liabilities:

Accounts payable

1,547

2,279

Contract liabilities

761

593

Other payables and accrued expenses

895

1,050

Current portion of long-term operating lease liabilities

127

83

──────

──────

Total current liabilities

3,330

4,005

──────

──────

Long-term operating lease liabilities, net of current portion

95

9

──────

──────

Total non-current liabilities

95

9

──────

──────

TOTAL LIABILITIES

3,425

4,014

──────

──────

Commitments and contingencies

–

–

SHAREHOLDERS’ EQUITY:

Ordinary share,

20,000,000 shares authorized and no par value; 7,899,832 and 7,899,832
shares issued as of June 30, 2025 and  December 31, 2024, respectively

123

123

Additional paid-in capital

9,774

9,774

Treasury stock, 330,306 and 183,533 shares at cost as of June 30, 2025 and
  December 31, 2024, respectively

(981)

(807)

PRC statutory reserves

345

345

Accumulated other comprehensive income

734

713

Retained earnings

5,468

5,595

──────

──────

Total shareholders’ equity attributable to Euro Tech Holdings Company
  Limited

15,463

15,743

Noncontrolling interests

911

951

──────

──────

Shareholders’ equity

16,374

16,694

──────

──────

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

19,799

20,708

══════

══════

EURO TECH HOLDINGS COMPANY LIMITED

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME
FOR THE SIX MONTHS ENDED JUNE 30, 2025 AND 2024

2025

(Unaudited)

2024

(Unaudited)

US$’000

US$’000

Revenue, net:

Trading and manufacturing

3,424

5,138

Engineering

2,464

2,121

────────

────────

5,888

7,259

Cost of revenue:

Trading and manufacturing

(2,566)

(3,997)

Engineering

(1,625)

(1,472)

────────

────────

(4,191)

(5,469)

────────

────────

Gross profit

1,697

1,790

Operating expenses:

 Finance costs

–

(1)

 General and administrative expenses

(2,065)

(2,167)

────────

────────

LOSS FROM OPERATION

(368)

(378)

Interest income

43

45

Other income, net

10

10

Equity in income of affiliates

148

232

────────

────────

LOSS BEFORE INCOME TAXES

(167)

(91)

Income tax credit / (expense)

3

(10)

────────

────────

NET LOSS

(164)

(101)

Net loss attributable to noncontrolling interests

37

145

────────

────────

Net  (loss) / income attributable to Euro Tech
  Holdings Company Limited

(127)

44

════════

════════

Other comprehensive (loss)

    Net (loss)

(164)

(101)

    Foreign currency adjustments

21

(9)

────────

────────

COMPREHENSIVE LOSS

(143)

(110)

Comprehensive (income) / loss attributable to
  noncontrolling interests

(3)

151

────────

────────

Comprehensive (loss) / income attributable
  to Euro Tech Holdings Company Limited

(146)

41

════════

════════

Net (loss) / income per ordinary share
  attributable to Euro Tech Holdings
  Company Limited

– Basic

$  US(0.02)

$  US0.01

════════

════════

– Diluted

$  US(0.02)

$  US0.01

════════

════════

Weighted average number of ordinary
  shares outstanding

– Basic

7,660,243

7,717,695

════════

════════

– Diluted

7,660,243

7,717,695

════════

════════

 

Cango Inc. Secures US$10.5 Million Investment from EWCL to Accelerate Growth

By
Advertorial Desk
-

DALLAS, Dec. 30, 2025 /PRNewswire/ — Cango Inc. (NYSE: CANG) (“Cango” or the “Company”), a leading Bitcoin miner leveraging its global operations to develop an integrated energy and AI compute platform, announced that Enduring Wealth Capital Limited (“EWCL”) increased its investment in the Company with a US$10.5 million commitment. EWCL will subscribe for additional Class B ordinary shares in cash at US$1.50 per share. This transaction underscores a strong, aligned vision for Cango’s future and provides substantial capital to accelerate its core growth initiatives.

Under the terms of this agreement:

  • Pursuant to an Investment Agreement dated December 29, 2025, between the Company and EWCL, the Company will issue and deliver to EWCL 7 million Class B ordinary shares, each carrying 20 votes per share.
  • Upon closing of the Proposed Investment, EWCL’s shareholding in the Company is expected to increase from approximately 2.81% to approximately 4.69% of the total outstanding shares.
  • Correspondingly, EWCL’s voting power is expected to rise from approximately 36.68% to approximately 49.61% of the total voting power of the Company’s outstanding shares.

Paul Yu, CEO and Director of Cango, commented, “The increased investment from EWCL is a powerful vote of confidence in our strategic roadmap. The strengthened alignment with a major shareholder who thoroughly understands our vision enables us to execute with greater certainty and ambition. In 2026, we will continue to strengthen our Bitcoin mining operational capabilities, with a focus on improving hashrate efficiency, upgrading our mining fleet, and selectively acquiring strategic mining assets. Beyond our core mining business, this capital also supports the parallel development of our strategic pillars in energy and AI compute. We are actively exploring and investing in synergistic opportunities in these areas as we build toward our long-term goal: establishing an integrated, global infrastructure platform capable of powering the future digital economy.”

Closing of the Proposed Investment is subject to certain customary closing conditions, including the requisite approval by the New York Stock Exchange. The Company expects to close the transaction in January 2026. This step is expected to support the Company’s progress on its strategic priorities and provide capital to implement key initiatives in the year ahead.

Investor Relations Contact

Juliet Ye, Head of Communications
Cango Inc.
Email: ir@cangoonline.com 

Christensen Advisory
Tel: +852 2117 0861
Email: cango@christensencomms.com

Uni-Bio Science Joins Forces with WMU NERC and Ouhai District Government to Build Growth Factor Innovation Ecosystem and Accelerate Regenerative Medicine Strategy Layout

By
Advertorial Desk
-

HONG KONG SAR – EQS Newswire – 30 December 2025 – Uni-Bio Science Group Limited (“Uni-Bio Science Group”, “Uni-Bio” or “the Group”) is pleased to announce the official signing of a tripartite strategic cooperation agreement in Wenzhou, Zhejiang, with the National Engineering Research Center for Cell Growth Factor Drugs and Protein Formulations of Wenzhou Medical University (“WMU NERC”) and the People’s Government of Ouhai District, Wenzhou. The parties also explored the subsequent co-establishment of the “Uni-Bio – WMU Joint Innovation Laboratory for Translational Medicine.” This collaboration marks a key step for Uni-Bio in deeply integrating with a national-level research platform and a regional industrial ecosystem. Through a synergistic “government-university-enterprise” model, the three parties will focus on the core regenerative medicine field of growth factors to establish an end-to-end innovation system spanning basic research, clinical translation, and industrial application. This represents a milestone for the Group in consolidating its R&D pipeline and accelerating its strategic execution.

Strategic cooperation signing ceremony group photo
Strategic cooperation signing ceremony group photo

Focusing on Growth Factor Frontiers, Unleashing “1+1>2” Clinical and Market Potential

Growth factors are key signaling molecules that regulate cell proliferation, migration, and tissue repair, representing some of the most transformative bioactive substances in regenerative medicine. Both EGF (Epidermal Growth Factor) and FGF (Fibroblast Growth Factor) have demonstrated significant efficacy across major indications, including wound healing, ophthalmic diseases, and metabolic disorders, underscoring their substantial market potential.

Uni-Bio possesses deep expertise in the EGF field, with its flagship products GeneTime® and GeneSoft® achieving large-scale production and nationwide commercial coverage. Concurrently, under the leadership of Academician Li Xiaokun, the WMU NERC has been a global pioneer in FGF drug R&D, having successfully translated several Class I New Drugs – including Recombinant Human Basic Fibroblast Growth Factor – and has accumulated substantial clinical data and authoritative expert consensus in trauma and metabolic diseases.

Building on this foundation, the three parties will initiate collaborative research on combined EGF/FGF therapies for key areas, including burns, dermatology, and ophthalmology. The goal is to unlock powerful therapeutic synergies, develop superior combination products and advance delivery systems, set new treatment benchmarks, and establish a leadership position in shaping this multi-billion Yuan sector.

Empowered by Academician Leadership & Platform, Creating a Fast Track from R&D to Production

The WMU NERC is an independent legal entity established by Wenzhou Medical University based on the national-level platform, the National Engineering Research Center for Cell Growth Factor Drugs and Protein Preparations. It undertakes downstream functions including engineering technology research and development, transformation of scientific and technological achievements, and technical services. In synergistic collaboration with the National Key Laboratory for Macromolecular Drugs and Large-Scale Preparation, which focuses on upstream basic research, the Center has built a next-generation growth factor drug pipeline targeting multiple systems such as metabolism and dermatology. Through the ongoing research of Academician Li Xiaokun’s team, the Center has achieved internationally leading breakthroughs in key technologies, including long-acting Modification, targeted delivery, and aerosol inhalation.

The planned “Uni-Bio – WMU Joint Innovation Laboratory for Translational Medicine” will conduct in-depth research into the synergistic mechanisms of Epidermal Growth Factor (EGF) and Fibroblast Growth Factor (FGF) in regulating metabolic homeostasis, improving insulin sensitivity, and promoting tissue repair. It aims to develop novel compound formulations and drug delivery systems targeting conditions such as endocrine diseases represented by non-alcoholic steatohepatitis (NASH), respiratory diseases represented by asthma, as well as bone tissue repair. These diseases affect a large global patient population, yet there remains a significant unmet clinical need for innovative therapies. Through this collaboration, it is expected to address treatment gaps in multiple specific indications, further unlocking clinical and commercial value in the broad chronic disease market.

The “Government-University-Enterprise ” Trinity, Systematically Strengthening Full-Chain Capabilities

This collaboration extends beyond technological synergy to ecosystem co-development. The People’s Government of Ouhai District, Wenzhou, is a key facilitator and supporter of this strategic cooperation, committed to building a first-class biomedical industry ecosystem. Its core platform, the “China Gene Valley,” will provide comprehensive spatial support and specialized policy assistance for the cooperative projects across all stages – from R&D and pilot-scale testing to industrialization.

For Uni-Bio, this tripartite cooperation delivers threefold empowerment:

  • R&D Front: Direct access to the National Engineering Research Center’s source innovation and core technologies, elevating the starting point of R&D.
  • Clinical Front: Collaboration with Wenzhou Medical University’s affiliated hospital network to accelerate clinical validation and indication expansion.
  • Commercialization Front: Leveraging the advanced manufacturing capabilities and regional policy benefits of the China Gene Valley to ensure efficient project implementation and facilitate market access.

This strategic partnership is a crucial step in the Group’s pursuit of its vision “To Be the Global Leader in Regenerative Medicine, Redefining How Science Restores and Extends Human Life” Moving forward, the Group will continue to deepen collaborations with national scientific institutions and local governments, driving the translation of more cutting-edge research into clinical and market value. This will further consolidate and enhance its comprehensive competitiveness and leadership in regenerative medicine.
Hashtag: #Uni-BioScience

The issuer is solely responsible for the content of this announcement.

About Uni-Bio Science:

Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise listed on the Main Board of The Stock Exchange of Hong Kong Limited in 2001(Stock Code: 00690.HK). The Group is committed to powering the advancement of regenerative medicine with next-generation synthetic biology and complex peptide innovation. Focusing on four core research areas—muscular-skeletal regeneration, skin regeneration, ocular regeneration, and ENT regeneration—the Group has built a diversified product pipeline encompassing innovative biologics, high-value generic drugs, and medical aesthetics. The Group operates GMP-compliant production bases in Beijing, Dongguan, and Shenzhen, with fully integrated capabilities spanning R&D, manufacturing, and commercial sales. Uni-Bio Science Group is dedicated to becoming a global leader in regenerative medicine, redefining how science restores and extends human life.

About the National Engineering Research Center for Cell Growth Factor Drugs and Protein Formulations of Wenzhou Medical University:

The WMU NERC is an independent legal entity established by Wenzhou Medical University based on the national-level platform, the National Engineering Research Center for Cell Growth Factor Drugs and Protein Preparations. It undertakes downstream functions including engineering technology research and development, transformation of scientific and technological achievements, and technical services. Under the leadership of Chinese Academy of Engineering Academician Li Xiaokun, the Center has long been engaged in foundational research and novel drug discovery for cell growth factor drugs, holding a globally leading position. It brings together top-tier scientific teams, undertakes major national science and technology projects, and has successfully developed a series of innovative FGF drugs with independent intellectual property rights. Through synergistic collaboration with the National Key Laboratory for Macromolecular Drugs and Large‑Scale Preparation, the Center forms a complete innovation chain from source discovery and key technological breakthroughs to industrial translation. As the important R&D engine of the China Gene Valley, it continuously promotes the incubation and translation of several original new drug candidates, including a long-acting FGF21 variant.

About the People’s Government of Ouhai District, Wenzhou:
The People’s Government of Ouhai District, Wenzhou, is a key facilitator and supporter of this strategic cooperation, committed to building a first-class biomedical industry ecosystem. Its core platform, the “China Gene Valley,” will provide comprehensive spatial support and specialized policy assistance for the cooperative projects across all stages – from R&D and pilot-scale testing to industrialization. Through specialized industrial policies, “full-cycle escort” services, and clinical resource coordination, Ouhai District empowers the implementation and growth of innovation projects, serving as a vital driver for regional biomedical industry innovation and development.

Huawei and PEA Jointly Release Next-Gen Intelligent Substation Solution

By
Advertorial Desk
-

BANGKOK, THAILAND – Media OutReach Newswire – 30 December 2025 – An event themed “AI Empowers New-Gen Intelligent Substations” was successfully held in Bangkok where Huawei and Thailand’s Provincial Electricity Authority (PEA) jointly unveiled an innovative next-gen intelligent substation solution, marking a new milestone in the digital and intelligent transformation of Thailand’s power infrastructure.

pea-innovative-practice

William Zhang, President of Enterprise Business at Huawei Thailand, stated, “The new power system faces trends such as green energy integration and interactive power consumption. Digitalization and intelligence are key to addressing these challenges. As critical nodes in the grid, substations must be upgraded to enhance overall reliability. The solution we launched with PEA uses optical-visual linkage and AI-based predictive maintenance to enable intelligent inspections and efficient O&M, ensuring substations run safely, reliably, and efficiently.”

Pantong Thinsatit, Assistant Governor for Grid Network Operations at PEA, added, “Digital transformation is essential for high-quality development in the power industry. PEA is accelerating substation intelligence by harnessing innovation to reshape energy services. We’ve deployed intelligent unattended systems in 467 substations, using cutting-edge technology to ensure safe operations. Moving forward, we will push for full automation, eliminate data silos, and integrate smart poles, license plate recognition, battery monitoring, and emergency buttons for rapid, precise responses. This will make intelligent substations central to the energy ecosystem and provide a replicable model for industry-wide digital transformation.”

Traditional substations often struggle with three major issues: limited security monitoring, inefficient and error-prone manual inspections, and outdated cabling that causes high latency and poor stability, restricting multi-service processing and intelligent scheduling. Huawei’s solution tackles these challenges with three core capabilities:

Perimeter Protection—All-Weather Digital Security

Using fiber optic sensing and AI algorithms, the system automatically detects intrusions, links with video surveillance devices, and allows remote verification—shifting from reactive to proactive security with round-the-clock monitoring.

Intelligent Inspection—Innovative Maintenance

Multi-scenario AI inspection algorithms, computer vision models, and cloud-edge collaboration support automatic meter reading and transformer oil leakage warnings, enabling real-time remote management and minute-level fault responses.

Full Connectivity—Comprehensive Sensing Network

Intra-station passive optical networks (PONs) significantly reduce deployment time and costs, forming the power grid’s “nervous system” to deliver reliable, high-speed connectivity for intelligent O&M.

This joint achievement underscores Huawei and PEA’s progress in technological innovation and ecosystem cooperation. Looking ahead, Huawei will continue to work closely with Thai power companies and partners to accelerate the digital and intelligent transformation of the power sector.
Hashtag: #Huawei

The issuer is solely responsible for the content of this announcement.

1...1,4651,4661,467...6,560Page 1,466 of 6,560